Hull, United Kingdom

David Alston

This inventor holds 1 USPTO granted patent. Top assignee: Smith Kline & French Laboratories Limited. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Alston. Retrieved from https://idiyas.com/inventor/david-alston

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David Alston

Introduction

David Alston is a notable inventor based in Hull, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cholesterol-lowering agents. His work has led to the creation of innovative compounds that have the potential to improve health outcomes.

Latest Patents

David Alston holds a patent for "Compounds - Polymethacrylate polymers, pharmaceutical compositions containing them and their use in medicine as cholesterol lowering agents." A particular polymer of his invention is the 11-N,N,N-trimethylammonioundecyl methacrylate chloride copolymer. This patent highlights his expertise in polymer chemistry and its applications in medicine.

Career Highlights

Alston is associated with Smith Kline & French Laboratories Limited, where he has been instrumental in advancing pharmaceutical research. His work has not only contributed to the company's portfolio but has also had a broader impact on the medical community.

Collaborations

Throughout his career, David Alston has collaborated with esteemed colleagues such as Albert A Jaxa-Chamiec and Deirdre M Hickey. These partnerships have fostered innovation and have been crucial in the development of his patented technologies.

Conclusion

David Alston's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…